Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mulder

Showing results (361-370 of 429) with videos related to

Pageof 43
Sort By:
British Journal of Clinical Pharmacology|August 27, 2005
Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patientsBregt S Kappelhoff, Alwin D R Huitema, Sanjay U C Sankatsing, et al.
Nature Cell Biology|May 16, 2017
Wounding induces dedifferentiation of epidermal Gata6<sup>+</sup> cells and acquisition of stem cell propertiesGiacomo Donati, Emanuel Rognoni, Toru Hiratsuka, et al.
Therapeutic Drug Monitoring|July 17, 2004
Race is not associated with nevirapine pharmacokineticsMonique M R de Maat, Jeannine F J B Nellen, Alwin D R Huitema, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individualsA I Veldkamp, R P van Heeswijk, J W Mulder, et al.
AIDS (London, England)|December 20, 2007
Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcriptionServi J C Stevens, Paul H M Smits, Sandra A W M Verkuijlen, et al.
Clinical and Experimental Immunology|January 1, 1992
Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infectionR J Klaassen, R Goldschmeding, K M Dolman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 20, 2002
Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patientsB S N Blank, P L Meenhorst, W Pauw, et al.
Nano Letters|November 6, 2023
High Affinity Electrostatic Interactions Support the Formation of CdS Quantum Dot:Nitrogenase MoFe Protein ComplexesLauren M Pellows, Mark A Willis, Jesse L Ruzicka, et al.
British Journal of Clinical Pharmacology|September 29, 2005
Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patientsK M L Crommentuyn, B S Kappelhoff, J W Mulder, et al.
British Journal of Clinical Pharmacology|January 29, 2005
Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patientsBregt S Kappelhoff, Alwin D R Huitema, Kristel M L Crommentuyn, et al.
Pageof 43

Showing results (361-370 of 429) with videos related to

Sort By:
Pageof 43
British Journal of Clinical Pharmacology|August 27, 2005
Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patientsBregt S Kappelhoff, Alwin D R Huitema, Sanjay U C Sankatsing, et al.
Nature Cell Biology|May 16, 2017
Wounding induces dedifferentiation of epidermal Gata6<sup>+</sup> cells and acquisition of stem cell propertiesGiacomo Donati, Emanuel Rognoni, Toru Hiratsuka, et al.
Therapeutic Drug Monitoring|July 17, 2004
Race is not associated with nevirapine pharmacokineticsMonique M R de Maat, Jeannine F J B Nellen, Alwin D R Huitema, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individualsA I Veldkamp, R P van Heeswijk, J W Mulder, et al.
AIDS (London, England)|December 20, 2007
Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcriptionServi J C Stevens, Paul H M Smits, Sandra A W M Verkuijlen, et al.
Clinical and Experimental Immunology|January 1, 1992
Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infectionR J Klaassen, R Goldschmeding, K M Dolman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 20, 2002
Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patientsB S N Blank, P L Meenhorst, W Pauw, et al.
Nano Letters|November 6, 2023
High Affinity Electrostatic Interactions Support the Formation of CdS Quantum Dot:Nitrogenase MoFe Protein ComplexesLauren M Pellows, Mark A Willis, Jesse L Ruzicka, et al.
British Journal of Clinical Pharmacology|September 29, 2005
Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patientsK M L Crommentuyn, B S Kappelhoff, J W Mulder, et al.
British Journal of Clinical Pharmacology|January 29, 2005
Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patientsBregt S Kappelhoff, Alwin D R Huitema, Kristel M L Crommentuyn, et al.
Pageof 43